News
Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics
Ziopharm Oncology, Inc. (NASDAQ: ZIOP) and Celldex Therapeutics, Inc. (NASDAQ: CLDX) are both clinical-stage biotechs that could make you rich, but they'll need to carry at least one of their new....
Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics
Ziopharm Oncology, Inc. (NASDAQ: ZIOP) and Celldex Therapeutics, Inc. (NASDAQ: CLDX) are both clinical-stage biotechs that could make you rich, but they'll need to carry at least one of their new....
Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics
Ziopharm Oncology, Inc. (NASDAQ: ZIOP) and Celldex Therapeutics, Inc. (NASDAQ: CLDX) are both clinical-stage biotechs that could make you rich, but they'll need to carry at least one of their new....
The Country's Biggest Insurer Got Even Bigger in Q3
UnitedHealth Group (NYSE: UNH) is the largest health insurer in the country, and strong financial results in the third quarter show the company's still growing in spite of its decision last year....
The Country's Biggest Insurer Got Even Bigger in Q3
UnitedHealth Group (NYSE: UNH) is the largest health insurer in the country, and strong financial results in the third quarter show the company's still growing in spite of its decision last year....
Here's Why AVEO Pharmaceuticals Dropped as Much as 16.3% Today
Shares of surprise biopharma AVEO Pharmaceuticals (NASDAQ: AVEO) dropped over 16% today on nearly twice the daily average trading volume without any major news story breaking. What's going on?....
Johnson & Johnson Q3 2017 Earnings Conference Call Transcript (JNJ)
Johnson & Johnson (NYSE: JNJ)Image source: The Motley Fool.Q3 2017 Earnings Conference CallOctober 17, 2017, 8:30 a.m. ETContinue readingSource: Fool.com
Johnson & Johnson Q3 2017 Earnings Conference Call Transcript (JNJ)
Johnson & Johnson (NYSE: JNJ)Image source: The Motley Fool.Q3 2017 Earnings Conference CallOctober 17, 2017, 8:30 a.m. ETContinue readingSource: Fool.com
Johnson & Johnson Jumps on Pharma Strength
Johnson & Johnson (NYSE: JNJ) has been a behemoth in the U.S. healthcare space for decades. Yet as a mature company, J&J faces the inevitable challenge of finding ways to keep its growth....
Johnson & Johnson Jumps on Pharma Strength
Johnson & Johnson (NYSE: JNJ) has been a behemoth in the U.S. healthcare space for decades. Yet as a mature company, J&J faces the inevitable challenge of finding ways to keep its growth....
Why TransEnterix Stock Is Soaring Today
Shares of the robotic-surgery company TransEnterix (NYSEMKT: TRXC) rose by as much as 69% today in early morning trading. This small-cap healthcare stock has now appreciated by over 200% since the....
Why TransEnterix Stock Is Soaring Today
Shares of the robotic-surgery company TransEnterix (NYSEMKT: TRXC) rose by as much as 69% today in early morning trading. This small-cap healthcare stock has now appreciated by over 200% since the....
Why Exelixis' Rebound Is Just Getting Started
Exelixis (NASDAQ: EXEL) stock had been in the doldrums. After roaring for much of the first eight months of the year, the biotech's share price sank more than 15% during September. All of that is....
3 Drug Stocks Hitting 52-Week Highs: Are They Buys?
October has often been a scary month for stocks. That isn't the case so far this year, though. And it's especially not true for three drug stocks.Biogen (NASDAQ: BIIB), Halozyme Therapeutics....
Should Intuitive Surgical Be Worried About Tiny TransEnterix?
TransEnterix (NYSEMKT: TRXC) shareholders have every reason to be excited. The U.S. Food and Drug Administration cleared the way for the company to market its Senhance Surgical Robotic System on....
Where Will Opko Health Inc. Be in 5 Years?
Opko Health (NASDAQ: OPK) has had a rough year no matter how you look at it. So far in 2017, shares of the pharmaceutical and diagnostics company are down more than 20%. At one point, Opko stock....
Why TG Therapeutics Is Tumbling 15% Today
After TG Therapeutics, Inc.'s(NASDAQ: TGTX) discussion with the FDA regarding its most advanced clinical-stage drug raised concerns over a speedy approval, shares in the company are losing 15% of....
Why TG Therapeutics Is Tumbling 15% Today
After TG Therapeutics, Inc.'s(NASDAQ: TGTX) discussion with the FDA regarding its most advanced clinical-stage drug raised concerns over a speedy approval, shares in the company are losing 15% of....
Why Exelixis, Inc. Rose Higher Today
Exelixis (NASDAQ: EXEL) is up 24% at 12:21 p.m. EDT after announcing that the phase 3 Celestial trial met its primary endpoint of helping liver cancer patients taking Cabometyx live longer than....
Why TransEnterix Is Skyrocketing Today
After the small-cap medical device company announced the Food and Drug Administration approval of its Senhance Surgical Robotic System, shares of TransEnterix (NYSEMKT: TRXC) jumped 75% as of 9:55....
Why TransEnterix Is Skyrocketing Today
After the small-cap medical device company announced the Food and Drug Administration approval of its Senhance Surgical Robotic System, shares of TransEnterix (NYSEMKT: TRXC) jumped 75% as of 9:55....
Why TransEnterix Is Skyrocketing Today
After the small-cap medical device company announced the Food and Drug Administration approval of its Senhance Surgical Robotic System, shares of TransEnterix (NYSEMKT: TRXC) jumped 75% as of 9:55....
3 Marijuana Stocks That Like to Live Life Dangerously
In case you haven't noticed, marijuana stocks are absolutely on fire. Many of the largest pot stocks by market cap have seen their valuations double, triple, or perhaps head even higher over the....
3 Questions You Need to Ask Ahead of Johnson & Johnson's Third-Quarter Report
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is what you might call a staple holding in many investors' portfolios. Its superior 2.5% dividend yield and 55-year streak of raising its....
3 Questions You Need to Ask Ahead of Johnson & Johnson's Third-Quarter Report
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is what you might call a staple holding in many investors' portfolios. Its superior 2.5% dividend yield and 55-year streak of raising its....